Friday, May 1, 2026

SpaceX Buys xAI in a $1.25 Trillion Deal: Elon Musk Says AI Data Centers Belong in Space

SpaceX merges with xAI to create a powerful innovation engine, aiming for space-based AI data centers to meet global power demands.

North Korea Condemns Japan’s Naval Exercises with U.S. and France

North Korea criticizes Japan's military exercises with the U.S. and France, warning against a revival of imperial ambitions.

Saudi Arabia’s Hajj Disaster: Heat and Crowds Claim Over a Thousand Lives

The death toll from the Hajj, the...

Tag: solid tumors

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.